48,847
edits
m (→IHC) |
|||
Line 271: | Line 271: | ||
Features: | Features: | ||
*MAP-2 +ve.<reF name=pmid12025943>{{cite journal |author=Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B |title=MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration |journal=J. Neuropathol. Exp. Neurol. |volume=61 |issue=5 |pages=403–12 |year=2002 |month=May |pmid=12025943 |doi= |url=}}</ref> | *MAP-2 +ve.<reF name=pmid12025943>{{cite journal |author=Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B |title=MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration |journal=J. Neuropathol. Exp. Neurol. |volume=61 |issue=5 |pages=403–12 |year=2002 |month=May |pmid=12025943 |doi= |url=}}</ref> | ||
*GFAP -ve. | *GFAP -ve. | ||
**Some subtypes +ve - should not be used to distinguish.<ref name=Ref_PNSP>{{Ref PNSP|98}}</ref> | |||
*EMA +ve. | *EMA +ve. | ||
*IDH-1 -ve. (???). | *IDH-1 -ve. (???). | ||
*p53 -ve. | *p53 -ve. | ||
**Useful for differentiating ''astrocytoma'' vs. ''oligodendroglioma''. | |||
*Ki-67. | *Ki-67. | ||
edits